Highlights from the plenary session: eosinophilic granulomatosis with polyangiitis and hypereosinophilic syndrome

被引：0
|
作者：
Holle, Julia U. [1 ,2 ]
Vaglio, Augusto [3 ,4 ]
机构：
[1] Rheumazentrum Schleswig Holstein Mitte, Kuhberg 5A-7, D-24534 Neumunster, Germany
[2] Rheumazentrum Schleswig Holstein Mitte, Sophienblatt 13-17, D-24113 Kiel, Germany
[3] Meyer Childrens Hosp IRCCS, Nephrol & Dialysis Unit, Florence, Italy
[4] Univ Florence, Dept Biomed Expt & Clin Sci Mario Serio, Florence, Italy
来源：
RHEUMATOLOGY | 2025年 / 64卷
关键词：
hypereosinophilic syndrome; eosinophilic granulomatosis with polyangiitis; anti-IL-5; benralizumab; mepolizumab; CHURG-STRAUSS; AMERICAN-COLLEGE; MEPOLIZUMAB; EFFICACY; PLACEBO; SAFETY; MANAGEMENT; VASCULITIS;
D O I：
10.1093/rheumatology/keae608
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Hypereosinophilic syndrome (HES) and eosinophilic granulomatosis with polyangiitis (EGPA) both present with hypereosinophilia and organ damage induced by eosinophils. EGPA is also characterized by vasculitis and is associated with ANCA. Yet, discriminating HES from EGPA may be difficult in clinical practice as biomarkers to reliably differentiate between HES and EGPA are still lacking. In recent years, it has been demonstrated that targeting IL-5 is efficacious to treat HES and EGPA, and the use of anti-IL-5(R)-antibodies has become a mainstay of therapy in HES and these diseases. Nonetheless, it remains unclear whether anti-IL-5 strategies are sufficient to treat organ-threatening eosinophilic manifestations or vasculitic manifestations in EGPA.
引用
收藏
页码：i92 / i97
页数：6
相关论文
共 50 条
  • [1] Biologics in Hypereosinophilic Syndrome and Eosinophilic Granulomatosis with Polyangiitis
    Ezekwe, Ejiofor
    Weskamp, Andrew L.
    Pittman, Luke M.
    Klion, Amy D.
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2024, 44 (04) : 629 - 644
  • [2] Distinct features of hypereosinophilic syndrome with neuropathy from eosinophilic granulomatosis with polyangiitis
    Takeuchi, Hiroki
    Kawamura, Kazuyuki
    Kawasaki, Teruaki
    Oka, Nobuyuki
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [3] Eosinophilia: hypereosinophilic syndrome vs. eosinophilic granulomatosis with polyangiitis
    Holle, Julia U.
    Moosig, Frank
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2023, 82 (04): : 307 - 320
  • [4] Unmet needs and evidence gaps in hypereosinophilic syndrome and eosinophilic granulomatosis with polyangiitis
    Wechsler, Michael E.
    Hellmich, Bernhard
    Cid, Maria C.
    Jayne, David
    Tian, Xinping
    Baylis, Lee
    Roufosse, Florence
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (06) : 1415 - 1428
  • [5] HYPEREOSINOPHILIC SYNDROME VS. EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS: THE SYMPTOMATIC DILEMMA
    Brown, S.
    Danelyan, H.
    Chepuru, R.
    Khoylyan, A.
    Jew, K.
    Tachdjian, R.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S93 - S94
  • [6] Blood marker for differentiating among eosinophilic granulomatosis with polyangiitis, hypereosinophilic syndrome, and toxocariasis
    Koh, Y., I
    Yu, J. E.
    Sim, D. W.
    Kim, C. W.
    ALLERGY, 2019, 74 : 427 - 427
  • [7] Serum cytokine and chemokine levels in patients with eosinophilic granulomatosis with polyangiitis, hypereosinophilic syndrome, or eosinophilic asthma
    Pagnoux, C.
    Nair, P.
    Xi, Y.
    Khalidi, N. A.
    Carette, S.
    Cuthbertson, D.
    Grayson, P. C.
    Koening, C. L.
    Langford, C. A.
    McAlear, C. A.
    Moreland, L. W.
    Monach, P. A.
    Seo, P.
    Specks, U.
    Sreih, A. G.
    Ytterberg, S. R.
    Tyrrell, P. N.
    Merkel, P. A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 37 (02) : S40 - S44
  • [8] Current Approach to Diagnosis and Management of Pulmonary Eosinophilic Syndromes: Eosinophilic Pneumonias, Eosinophilic Granulomatosis with Polyangiitis, and Hypereosinophilic Syndrome
    Sergew, Amen
    Perez, Evans R. Fernandez
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 37 (03) : 441 - 456
  • [9] Hypereosinophilic syndrome and eosinophilic granulomatosis with polyangiitis: Eosinophilic-associated inflammatory conditions with a challenging diagnosis and treatment
    Konsek-Komorowska, Sonia J.
    Cyganski, Piotr
    KARDIOLOGIA POLSKA, 2022, 80 (09) : 962 - 963
  • [10] Can ANCA differentiate eosinophilic granulomatosis with polyangiitis(Churg-Strauss) from idiopathic hypereosinophilic syndrome?
    Zwerina, J.
    Strehl, J. D.
    Beyer, C.
    Schett, G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2013, 31 (06) : 989 - 990
12345